Cargando…
Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
Barcelona clinic liver cancer (BCLC) intermediate stage hepatocellular carcinoma is a heterogenous disease. Transarterial chemoembolization is offered as the first line therapy in this disease stage. Recent advances in systemic therapy have markedly improved outcomes even in advanced stage disease....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254139/ https://www.ncbi.nlm.nih.gov/pubmed/35949352 http://dx.doi.org/10.3748/wjg.v28.i23.2561 |